Sector
HealthcareOpen
₹18Prev. Close
₹18Turnover(Lac.)
₹0.11Day's High
₹18.1Day's Low
₹1852 Week's High
₹27.7352 Week's Low
₹10.56Book Value
₹22.97Face Value
₹10Mkt Cap (₹ Cr.)
7.4P/E
26.54EPS
0.68Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 4.15 | 4.15 | 4.15 | 4.15 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 5.32 | 5.15 | 5.37 | 4.88 |
Net Worth | 9.47 | 9.3 | 9.52 | 9.03 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Revenue | 9.78 | 18.2 | 16.93 | 13.81 |
yoy growth (%) | -46.27 | 7.52 | 22.54 | 23.21 |
Raw materials | -2.33 | -3.35 | -2.25 | -1.55 |
As % of sales | 23.82 | 18.4 | 13.32 | 11.28 |
Employee costs | -2.36 | -3.58 | -3.73 | -2.74 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Profit before tax | -1.63 | -0.31 | 0.11 | 0.67 |
Depreciation | -1.04 | -1.09 | -1.12 | -1.1 |
Tax paid | 0.2 | 0.05 | -0.06 | 0.05 |
Working capital | -0.23 | 0.41 | -0.8 | 0.18 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -46.27 | 7.52 | 22.54 | 23.21 |
Op profit growth | -212.67 | -46.09 | -33.43 | 57.24 |
EBIT growth | 489.54 | -218.04 | -74.08 | -21.74 |
Net profit growth | 438.61 | -664.38 | -93.57 | 33.37 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 6,885.35 | 94.46 | 99,000.77 | 251.7 | 0.23 | 1,936.6 | 536.28 |
Max Healthcare Institute Ltd MAXHEALTH | 923.2 | 125.43 | 89,747.23 | 154.14 | 0.16 | 621.39 | 79.01 |
Fortis Healthcare Ltd FORTIS | 594.5 | 339.71 | 44,882.26 | 26.83 | 0.17 | 333.4 | 120.36 |
Syngene International Ltd SYNGENE | 838.9 | 75.04 | 33,768.83 | 73.9 | 0.15 | 726.5 | 104.14 |
Dr Lal Pathlabs Ltd LALPATHLAB | 3,317.45 | 67.02 | 27,725.34 | 122.9 | 0.54 | 534.5 | 227.31 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Director
V S Phull
Managing Director
Shalini Sharma
Non-Exec & Non-Independent Dir
Meenaakashi Elhence
Non Executive Director
Premjit S Kashyap
Non-Exec. & Independent Dir.
Ashokkumar Singh Chaudhary
Non-Exec. & Independent Dir.
Ajay Rajpal
Company Sec. & Compli. Officer
Ritika Bhandari
Non Executive Director
Anil Elhence
Non Executive Director
Rowena Sharma
Non Executive Director
Tulsi Prasad
Independent Director
Mohd Haaris
Independent Director
AMITABH KRISHNA BHATIA
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Dhanvantri Jeevan Rekha Ltd
Summary
Dhanvantri Jeevan Rekha Limited, incorporated on June 11, 1993 is a multi speciality hospital providing reliable diagnostic and therapeutical services. Dhanvantri Hospital with advance and high-class patient care, made humble beginning around 30 years ago in 1993 at 1- Saket, Meerut. The Hospital has now grown to become a major healthcare provider to all walks of life in Meerut and the surrounding region. The Company was incorporated as a Public Limited Company with the Registrar of Companies in Uttar Pradesh with the main object of providing diagnostic and therapeutic services including Magnetic Resonance Imaging (MRI). It obtained Certificate for Commencement of Business on August 2, 1993. In October 1993, the Company acquired a constructed building at Saket, in Meerut for establishing the Diagnostic Centre. The renovation of the site was already completed. Diagnostic equipments in the Urology and Cardiology Sections were already installed and are in operation.The Company is engaged mainly providing Medical & Health-care Services to the public at large. Dhanvantri Hospital is one of the first comprehensive, multi-specialty setup in Western-Up with latest State-of-the-Art equipment for both diagnostic and therapeutic services under one roof. It provide efficient, patient oriented services in a friendly and clean environment at moderate rates. The Hospital offers diagnostic and therapeutic facilities in all specialities, well equipped multidisciplinary intensive care units a
Read More
The Dhanvantri Jeevan Rekha Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹18.05 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dhanvantri Jeevan Rekha Ltd is ₹7.40 Cr. as of 22 Oct ‘24
The PE and PB ratios of Dhanvantri Jeevan Rekha Ltd is 26.54 and 0.79 as of 22 Oct ‘24
The 52-week high/low is the highest and lowest price at which a Dhanvantri Jeevan Rekha Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Dhanvantri Jeevan Rekha Ltd is ₹10.56 and ₹27.73 as of 22 Oct ‘24
Dhanvantri Jeevan Rekha Ltd's CAGR for 5 Years at 12.00%, 3 Years at 28.13%, 1 Year at 49.05%, 6 Month at -15.42%, 3 Month at -14.05% and 1 Month at -11.95%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice